SavedAdd your journal

Journals / Yeni Tıp Dergisi / 2012 / Cilt: 29 - Sayı: 3

Alpha 1 antitrypsin deficiency

Alfa 1 antitripsin eksikliği

Akif ALTINBAŞ
Fuat EKİZ
Şahin ÇOBAN
Osman YÜKSEL
Pages
138–141
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

The aim of this review article is to determine importance of AAT deficieny in our country according to the data published from our country.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Alpha 1 antitrypsin (AAT) deficiency is a hereditary disorder leading to severe lung and liver diseases worldwide.
📊
Key Findings & Data:A recent study performed in our country revealed that 0.7% of healthy individials represent PI MZ allele and the most sensitive and spesific cuttoff value for AAT level in serum is 100.5 mg/dl.
💡
Conclusion & Impact:The aim of this review article is to determine importance of AAT deficieny in our country according to the data published from our country.
🔬Design:Review & Systematic Survey
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Alpha 1 antitrypsin (AAT) deficiency is a hereditary disorder leading to severe lung and liver diseases worldwide. In AAT deficiency, the defective defence system against neutrophil elastasis is implicated in lung disorders, whereas an accumulation of insoluble heterodimer AAT molecules in hepatocytes is the main cause of liver disorders. It is important to detect the prevalence of AAT deficiency in each country to organize the public health policy. Genotypic AAT molecule is defined as normal allele (PİMM), carrier (PİMS, PİMZ) and deficient allele (PİSS, PİSZ, PİZZ). Only to measure the level of AAT in serum does not help to detect all AAT deficiency. A recent study performed in our country revealed that 0.7% of healthy individials represent PI MZ allele and the most sensitive and spesific cuttoff value for AAT level in serum is 100.5 mg/dl. The aim of this review article is to determine importance of AAT deficieny in our country according to the data published from our country.

Özet

Alfa 1 antitripsin eksikliği, ciddi akciğer ve karaciğer hastalıklarına neden olabilen ve tüm dünya genelinde farklı oranlarda görülen genetik bir rahatsızlıktır. AAT eksikliği, neden olduğu nötrofil elastaza karşı yetersiz savunma sistemi ile akciğer hastalıklarına yol açarken, heterodimer AAT moleküllerinin hepatositte birikimiyle de karaciğer hastalıklarına yol açmaktadır. Halk sağlığı politikalarının oluşturulması amacıyla her toplumdaki AAT eksikliği sıklığının tespiti önemlidir. Genotipik olarak AAT, normal allel (PİMM), taşıyıcı (PİMS, PİMZ) ve eksik allel (PİSS, PİSZ, PİZZ) olarak üç grupta incelenmektedir. AAT eksikliğinin tespiti amacıyla sadece serum AAT düzeyinin ölçülmesi yetersiz kalmaktadır. Ülkemizde yapılan çalışmada, PI MZ allel sıklığı %0,7 olarak tespit edilmiş ve serum AAT düzeyi için kabul edilen 100,5 mg/dl’lik eşik değer ile en yüksek sensitif ve spesifik değere ulaşılmıştır. Bu derleme yazısının amacı, ülkemizde yapılan çalışmalar ışığında AAT eksikliğinin ülkemiz için bir sorun teşkil edip etmediğini ortaya koymaktır.

🔖

Cite This Article

ALTINBAŞ, A., EKİZ, F., ÇOBAN, Ş., YÜKSEL, O. (2012). Alpha 1 antitrypsin deficiency. Yeni Tıp Dergisi, Cilt: 29 - Sayı: 3, 138–141. https://ajindex.com/articles/338213

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (13)

  1. Primhak RA, Tanner MS. Alpha 1 antitrypsin deficiency. Arch Dis Child 2001;85:2-5.
  2. Massi G, Chiarelli. Alpha 1 antitrypsin: molecular structure and Pi system. Acta Paediatr Suppl 1994;393:1-4.
  3. Steiner SJ, Gupta SK, Croffie JM, Fitzgerald JF. Serum levels of alpha1-antitrypsin predict phenotypic expression of the alpha1-antitrypsin gene. Dig Dis Sci 2003;48:1793-6.
  4. Simsek H, Pınar A, Altınbas A, Alp A, Balaban YH, Buyukasık Y et al. Cut-off level to detect heterozygous alpha 1 antitrypsin deficiency in Turkish population. J Clin Lab Anal 2011;25:296–9. Hutchison DCS. Alpha 1 antitrypsin deficiency in Europe: geographical distrubition of Pi types S and Z. Respir Med 1998;92(3):367- 77. De Serres FJ. World wide racial and ethnic distrubition of Alpha 1 antitrypsin deficiency. Chest 2002;122:1818-29. Memoranda: Alpha 1 antitrypsin deficiency: Memorandum from a WHO meeting. Bull World Health Organ 1997;75(5):397-415.
  5. Sharp RR, De Serres FJ, Newman L, Sandhous RA, Walsh JW, Hood E, et al. Environmental occupational and genetic risc factors for Alpha 1 antitrypsin deficiency. Environ Health Perspect 2003;111(4):1749-52.
  6. Mailliard ME, Gollan JL. Metabolic liver disease in the young adult. Best Pract Res Clin Gastroenterol 2003;17(2):307-22
  7. Vennarecci G, Gunson BK, İsmail T, Hübscher SG, Kelly DA, McMaster P et al. Transplantation for end stage liver disease related to Alpha 1 antitrypsin deficiency. Transplantion 1996;61(10):1488-95.
  8. Berg NO, Ericsson S. Liver disease in adults with Alpha 1 antitrypsin deficiency. N Engl J Med 1972;287:1264-7. De Serres FJ. Alpha 1 antitrypsin deficiency is not a rare disease but a disease that is rarely diagnosed. Environ Health Perspect 2003;111 (16):1851-4.
  9. Carrell RW, Lomas DA. Alpha 1 antitrypsin deficiency- a model for conformational diseases. N Engl J Med 2002;346(1):45-53.
  10. Tecman JH, Qu D, Perlmutter DH. Molecular pathogenesis of liver disease in Alpha 1 antitrypsin deficiency. Hepatology 1996;24(6):1504-14.
  11. Teckman JH, Perlmutter DH. Retention of mutant Alpha 1 antitrypsin Z in endoplasmic reticulum is associated with an autophagic response. Am J Physiol Gastrointest Liver Physiol 2000;279:G961-G74. Perlmutter DH. Liver injury in alpha 1 antitrypsin deficiency: an aggreagted protein induces mitochondrial injury. J Clin Invest 2002;110 (11):1579-83.
  12. Lomas DA, Mahadeva R. Alpha 1 antitrypsin polymerization and the serpinopathies: pathobiology and prospects for therapy. J Clin Invest 2002;110(11):1585-90.
  13. Rudnick DA, Liao Y,